Preclinical imaging and radiotherapy of prostate cancer using the theranostic twins(68Ga/177Lu)-radiolabeled peptides

被引：0
|
作者：
Lim, J. C. [1 ]
Cho, E. H. [1 ]
Lee, S. Y. [1 ]
Dho, S. H. [1 ]
Kim, S. Y. [1 ]
Jung, S. H. [1 ]
机构：
[1] Korea Atom Energy Res Inst, Daejeon, South Korea
来源：
RADIOTHERAPY AND ONCOLOGY | 2016年 / 118卷
关键词：
Theranosis; Prostate cancer; Bombesin; Radionuclide;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
137
引用
收藏
页码：S67 / S68
页数：2
相关论文
共 50 条
  • [1] Preliminary Evaluation of Iron Oxide Nanoparticles Radiolabeled with 68Ga and 177Lu as Potential Theranostic Agents
    Salvanou, Evangelia-Alexandra
    Kolokithas-Ntoukas, Argiris
    Liolios, Christos
    Xanthopoulos, Stavros
    Paravatou-Petsotas, Maria
    Tsoukalas, Charalampos
    Avgoustakis, Konstantinos
    Bouziotis, Penelope
    NANOMATERIALS, 2022, 12 (14)
  • [2] Novel developed HPLC analyses of [68Ga]Ga/[177Lu]Lu-EDTMP and [68Ga]Ga/[177Lu]Lu-DOTA-Zoledronate
    Eryilmaz, Kurtulus
    Bakar, Hasan Ensar
    Kilbas, Benan
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2022, 65 (07): : 178 - 186
  • [3] Experimental study of 68Ga/177Lu PSMA I&T: A novel PSMA inhibitor for theranostic of prostate cancer
    Zhang, Lulu
    Zhang, Pengjun
    Wang, Feng
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2019, 62 : S528 - S529
  • [4] Preliminary evaluation of a novel PSMA-targeting radiopharmaceutical [68Ga]Ga/[177Lu]Lu-NYM032 for theranostic use in prostate cancer
    Fu, Haitian
    He, Huihui
    Wang, Yanjuan
    Li, Wenjin
    Luo, Yihui
    Chen, Liping
    Mi, Yuanyuan
    Sun, Chengwen
    Mao, Yong
    Yu, Chunjing
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2025, : 1671 - 1684
  • [5] Preclinical evaluation of novel theranostic heterodimeric ligands [68Ga]Ga/[177Lu]Lu-DOTA-FAPI-BPsfor tumor bone metastasis
    Deng, Y.
    Jin, W.
    Zhang, Z.
    Wang, X.
    Zhao, R.
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2024, 51 : S450 - S450
  • [6] Preparation and Preliminary Evaluation of Neurotensin Radiolabelled with 68Ga and 177Lu as Potential Theranostic Agent for Colon Cancer
    Leonte, Radu Anton
    Chilug, Livia Elena
    Serban, Radu
    Mustaciosu, Cosmin
    Raicu, Alina
    Manda, Gina
    Niculae, Dana
    PHARMACEUTICS, 2021, 13 (04)
  • [7] FEASIBILITY OF DUAL 68GA/177LU RADIONUCLIDE IMAGING FOR IMPROVED DOSIMETRY
    Marquis, H.
    Willowson, K.
    Bailey, D.
    INTERNAL MEDICINE JOURNAL, 2021, 51 : 30 - 30
  • [8] Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
    Jin, Wenbin
    Zhao, Ruiyue
    Wang, Ran
    Choi, Seok Rye
    Ploessl, Karl
    Alexoff, David
    Wu, Zehui
    Zhu, Lin
    Kung, Hank F.
    JOURNAL OF MEDICINAL CHEMISTRY, 2024, 67 (06) : 4793 - 4803
  • [9] Theranostic Agent Targeting Bone Metastasis: A Novel [68Ga]Ga/[177Lu]Lu-DOTA-HBED-bisphosphonate
    Jin, WenBin
    Wang, Ran
    Zhao, Ruiyue
    Choi, Seokye
    Ploessl, Karl
    Alexoff, David
    Zhu, Lin
    Kung, Hank
    JOURNAL OF NUCLEAR MEDICINE, 2024, 65
  • [10] 68Ga/177Lu-NeoBOMB1, a novel radiolabeled GRPR antagonist for theranostic use
    Dalm, Simone
    Bakker, Ingrid
    de Blois, Erik
    Doeswijk, Gabriela
    Konijnenberg, Mark
    Orlandi, Francesca
    Barbato, Donato
    Tedesco, Mattia
    Maina, Theodosia
    Nock, Berthold
    de Jong, Marion
    JOURNAL OF NUCLEAR MEDICINE, 2016, 57
12345